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COVID-19 has disrupted routine health 
service delivery and there is increasing use of 
digital interventions to reduce exposure of 
patients and healthcare workers to SARS- CoV-2 
infection.1 For HIV drug adherence moni-
toring, service providers may be of interest to 
adopt best practices in digital health but it is 
important that interventions described in trials 
can be replicated in real- world practice. Pooled 
analyses suggest that text message interventions 
are associated with increased adherence,2 but 
service providers should examine individual 
trials in detail before deciding on a specific 
approach.
For example, a randomised controlled 
trial by Gross et al3 in 2019 reported no 
effect of a two- way mobile- delivered inter-
vention on detectable viral load at 48 weeks 
among people taking antiretroviral therapy. 
However, a similar study by Lester et al4 in 
2010 did report an effect on viral suppression 
at 12 months.
Both trials evaluated two- way mobile phone 
interventions. In the Lester trial, participants 
were sent weekly Short Message Service ‘SMS’ 
messages in the local language asking ‘How are 
you?’ to which they were expected to respond 
by text message. In the Gross trial, participants 
were sent daily, and then weekly, SMS messages 
in the local language asking ‘Everything ok?’, 
to which they were expected to respond by 
calling a central number. In both trials, failure 
to respond to messages triggered an attempt 
at phone counselling by healthcare workers. 
In the Lester trial, 4171 out of 11 983 (35%) 
responses would have required a phone call. 
In the Gross trial, 248 out of 250 participants 
(99%) met the criteria for phone contact at 
least once. Despite both studies involving a 
significant amount of phone counselling, they 
have been described as ‘SMS interventions’ 
and the content and possible effect of phone 
counselling are not discussed.5
While it is possible that the effect of the inter-
ventions is attributable to the text messages, 
the possible role of phone counselling should 
be acknowledged. Phone counselling enables 
personalised support to be delivered. Concerns 
can be addressed and content tailored accord-
ingly in a way that is not possible with auto-
mated messages. However, phone counselling 
can be resource intensive and costly.
Distinctions should be made when pooling 
results of studies that use automated digital 
health interventions and those that include 
phone counselling. It is important to correctly 
describe the nature of digital health interven-
tions as this will have implications for replica-
bility and scale.
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